{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:53:56Z","timestamp":1791046436297,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.tips.2004.10.001","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T13:03:10Z","timestamp":1099746190000},"page":"609-612","source":"Crossref","is-referenced-by-count":174,"title":["Neuroprotection by tetracyclines"],"prefix":"10.1016","volume":"25","author":[{"given":"Mar\u00eda","family":"Domercq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Matute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2004.10.001_bib1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.STR.25.7.1411","article-title":"Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment","volume":"25","author":"Clark","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.tips.2004.10.001_bib2","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","article-title":"Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia","volume":"95","author":"Yrjanheikki","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2004.10.001_bib3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1212\/01.WNL.0000125321.92112.7E","article-title":"Placebo-controlled phase I\/II studies of minocycline in amyotrophic lateral sclerosis","volume":"62","author":"Gordon","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2004.10.001_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mds.20018","article-title":"Minocycline in Huntington's disease: a pilot study","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tips.2004.10.001_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/01.WNL.0000133403.30559.FF","article-title":"Minocycline safety and tolerability in Huntington disease","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2004.10.001_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.20111","article-title":"Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis","volume":"55","author":"Metz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib7","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window","volume":"96","author":"Yrjanheikki","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2004.10.001_bib8","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2004.10.001_bib9","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","article-title":"Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia","volume":"21","author":"Tikka","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2004.10.001_bib10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2004.10.001_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.tips.2004.10.001_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tips.2004.10.001_bib14","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2004.10.001_bib15","doi-asserted-by":"crossref","first-page":"19948","DOI":"10.1074\/jbc.M313629200","article-title":"Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2004.10.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-4-7","article-title":"Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats","volume":"4","author":"Xu","year":"2004","journal-title":"BMC Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.10242","article-title":"Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury","volume":"52","author":"Arvin","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2004.01.011","article-title":"Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model","volume":"189","author":"Tsuji","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","article-title":"The link between excitotoxic oligodendroglial death and demyelinating diseases","volume":"24","author":"Matute","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2004.10.001_bib20","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/brain\/awg178","article-title":"Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice","volume":"126","author":"Wells","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.tips.2004.10.001_bib21","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1523\/JNEUROSCI.5275-03.2004","article-title":"Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury","volume":"24","author":"Stirling","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2004.10.001_bib22","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.0306239101","article-title":"Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury","volume":"101","author":"Teng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2004.10.001_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2004.10.001_bib24","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1111\/j.0953-816X.2004.03439.x","article-title":"Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning","volume":"19","author":"Hunter","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tips.2004.10.001_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2004.10.001_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.10614","article-title":"Minocycline and doxycycline are not beneficial in a model of Huntington's disease","volume":"54","author":"Smith","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib27","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","article-title":"Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease","volume":"19","author":"Diguet","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tips.2004.10.001_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2004.10.001_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnet","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2004.10.001_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2003.12.006","article-title":"Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection","volume":"186","author":"Fagan","year":"2004","journal-title":"Exp. Neurol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614704002792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614704002792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T04:21:19Z","timestamp":1549081279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614704002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0165614704002792"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2004.10.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}